Journal Mobile Options
Table of Contents
Vol. 14, No. 1, 2005
Issue release date: January–February 2005
Section title: Original Paper
Open Access Gateway
Med Princ Pract 2005;14:35–40

Prognostic Factors in the Management of Exacerbation of Chronic Obstructive Pulmonary Disease in Kuwait

Onadeko B.O.a · Khadadah M.a · Abdella N.a · Mukhtar M.b · Mourou M.b · Qurtom M.b · Samad M.b · Al-Shayeb A.b
aDepartment of Medicine, Faculty of Medicine, Kuwait University and bMubarak Al-Kabeer Hospital, Kuwait
email Corresponding Author

Prof. B.O. Onadeko

PO Box 29279

Secretariat Post Office

Ibadan, Oyo State (Nigeria)

Tel./Fax +965 234 2 8100556, E-Mail


  1. Hurd S: The impact of COPD on lung health world wide: Epidemiology and incidence. Chest 2000;117(suppl 2):1s–4s.

    External Resources

  2. NHLB1/WHO Global Initiative for Chronic Obstructive Lung Disease. GOLD 2001, p 1.
  3. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995;152:S77–S120.
  4. BTS guidelines for management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997;52(suppl):S1–S28.
  5. Roberts CM, Ryland I, Lowe D, Kelly Y, Bucknall CE, Pearson MG: Audit of acute admissions of COPD: Standards of care and management in the hospital setting. Eur Respir J 2000;17:243–349.
  6. Boushy SF, Thompson HK, North LB, Beale AR, Snow TR: Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1973;108:1373–1383.
  7. Traver GA, Cline MG, Burrows B: Predictors of mortality in chronic obstructive pulmonary disease: A 15-year follow-up study. Am Rev Respir Dis 1979;119:895–902.
  8. Anthonisen NR, Wright EC, Hodgkins JE: Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:14–20.
  9. Postma DS, Gimeno F, van der Weele LT, Sluiter HJ: Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: The importance of reversibility. Eur J Respir Dis 1985;67:360–368.
  10. Almagro A, Calbo E, Ochoa de Echaguen A, Barreiro B, Quintana S, Heredia JL, Garau J: Mortality after hospitalization for COPD. Chest 2002;121:1441–1448.
  11. Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA: Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995;274:1852–1857.
  12. Connors AF, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA: Outcomes following acute exacerbation of chronic obstructive lung disease. Am J Respir Crit Care Med 1996;154:959–967.
  13. Memon A, Moody PM, Sugathan TN, El-Gerges N, Al-Bustan M, Al-Shattia A, Al-Jazzaf H: Epidemiology of smoking among Kuwaiti adults: Prevalence, characteristics and attitudes. Bull WHO 2000;78:1306–1315.
  14. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA: Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196–204.
  15. Balter MS, Hyland RH, Low DE: Recommendations on the management of chronic bronchitis: A practical guide for Canadian Physicians. Can Med Assoc J 1994;157(suppl 10):5–23.
  16. Kanner RE, Renzetti AD, Stannish WM, Barkman HW, Klanber MR: Predictor of survival in subjects with chronic airflow limitation. Am J Med 1983;74:249–255.
  17. Vestbo J, Prescott E, Lange P, Schnohr P, Jensen G: Vital prognosis after hospitalisation for COPD: A study of random population sample. Resp Med 1998;92:772–776.
  18. Dewan NA, Rafique S, Kanwar B, Satpathy H, Ryschan K, Tillotson GS, Niederman MS: Acute exacerbation of COPD: Factors associated with poor treatment outcome. Chest 2000;117:667–671.
  19. Ball P, Harris JM, Lowson D, Tillotson G, Wilson R: Acute infective exacerbations of chronic bronchitis. QJM 1995;88:61–68.
  20. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM: Risk factors for readmission to hospital for a COPD exacerbation: A prospective study. Thorax 2003;58:100–105.
  21. American Thoracic Society: Standards for diagnosis and care of patients with COPD. Am J Respir Crit Care Med 1995;152:S77–S120.
  22. US Surgeon-General 1984: The health consequences of smoking: Chronic obstructive lung disease. DHHS publication No 84–5020 J. Washington, US Department of Health and Human Services, 1984.
  23. Becklake MR: Chronic airflow limitations: Its relationship to work in dusty occupations. Chest 1988;88:608–617.
  24. Larson RK, Barman ML: The familial occurrence of chronic obstructive lung disease. Ann Intern Med 1965;63:1001–1008.
  25. Plank PK, Owen JL, Elliot MW: One year period prevalence study of respiratory acidosis in acute exacerbation of COPD: Implications for the provision of non-invasive ventilation and oxygen administration. Thorax 2000;55:550–554.
  26. Gibson PG, Wlodarczyk JH, Wilson AJ, Sprogis A: Severe exacerbation of chronic obstructive airways disease: Health resource use in general practice and hospital. J Qual Clin Pract 1998;18:125–133.
  27. Thompson WH, Nielsen CP, Carvalho P, Charan NB, Crowley JJ: Controlled trial of oral prednisolone in out-patients with acute COPD exacerbation. Am J Respir Crit Care Med 1996;154:407–412.
  28. Davies L, Angus RM, Calverley PM: Oral corticosteroids in patients admitted to hospital with exacerbation of chronic obstructive pulmonary disease: A prospective randomised controlled trial. Lancet 1999;354:456–460.
  29. Niewoehner DE, Erbland ML, Deupree RH, Collins C, Gross NJ, Light RW, Anderson P, Morgan NA: Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease: Department of Veterans Affairs Co-operative Study Group. N Engl J Med 1999;340:1941–1947.
  30. Kerstjens HAM, Brand PLP, Hughes M: A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992;327:1413–1419.
  31. Dompeling E, van Schayck CP, van Grunsven PM, van Herwaarden CL, Akkermans R, Molema J, Folgering H, van Weel C: Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids: A 4-year prospective study. Ann Intern Med 1993;118:770–778.
  32. Garcia-Aymerich J, Monso E, Marrades RM, Escarrabill J, Felez MA, Sunyer J, Anto JM: Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 2001;164:1002–1007.
  33. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981;i:681–686.
  34. Nocturnal Oxygen Therapy Trial Group: Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial. Ann Intern Med 1980;93:391–398.

    External Resources

  35. Johnson MK, Stevenson RD: Management of an acute exacerbation of COPD: Are we ignoring the evidence? Thorax 2002;57(suppl ii):15–23.
  36. Poole PJ, Black PN: Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: Systematic review. BMJ 2001;322:1271–1274.
  37. Stey C, Steurer J, Bachmann S, Medici TC, Tramer MR: The effect of oral N-acetylcysteine in chronic bronchitis: A quantitative systematic review. Eur Respir J 2000;16:253–262.
  38. Vincken W, Van Noord JA, Greefhorst APM, Bantje TA, Kesten S, Korducki L, Cornelissen PJ: Dutch/Belgian Tiotropium Study Group: Improved health outcomes in patients with COPD during 1 year’s treatment with tiotropium. Eur Respir J 2002;19:209–216.
  39. Casaburi R, Mahler DA, Jones PW, Wanner A, San Pedro G, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr: A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002;19:217–224.